- A double-blind, randomized crossover clinical study was carried out in Brazil
- Compare two brands of botulinum toxin type A in treating blepharospasm and hemifacial spasm
- No difference between BTXA™ and the other brand in terms of subjective global improvement, response onset, efficacy duration, and incidence and severity of adverse events
